C12N 2501/73
Hydrolases
Official title: Hydrolases (EC 3.)
C12N2501/73 (Hydrolases) appears on 174 US grants and 407 published applications in this corpus.
Search patents in C12N- Granted patents
- 174
- Published applications
- 407
- Assignees
- 270
- Inventors
- 922
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 3 |
| 2009 | 0 | 2 |
| 2010 | 0 | 2 |
| 2011 | 1 | 10 |
| 2012 | 1 | 7 |
| 2013 | 2 | 9 |
| 2014 | 5 | 12 |
| 2015 | 12 | 25 |
| 2016 | 15 | 32 |
| 2017 | 5 | 26 |
| 2018 | 19 | 26 |
| 2019 | 20 | 32 |
| 2020 | 9 | 30 |
| 2021 | 17 | 30 |
| 2022 | 12 | 36 |
| 2023 | 9 | 24 |
| 2024 | 18 | 30 |
| 2025 | 14 | 45 |
| 2026 | 15 | 23 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods of activating cells via PTP 1B inhibition29 Sep 2026US 12,746,285 B2Monash University
- Method for preserving fermentation broth of engineered strain of D-psicose-3-epimerase22 Sep 2026US 12,742,150 B2Henan Zhongda Hengyuan Biotechnology Stock Co., Ltd.
- Cell therapeutic agent for cancer treatment and combination therapy with same15 Sep 2026US 12,735,680 B2Cell & Brain Co., Ltd
- Methods for production of platelets from pluripotent stem cells and compositions thereof4 Aug 2026US RE50,977 E1Astellas Institute for Regenerative Medicine
- Media for culturing naive human pluripotent stem cells14 Jul 2026US 12,680,083 B2Yeda Research and Development Co. Ltd.
- Composition for inducing immunotolerance8 Oct 2026US 2026/0306540 A1
- Pluripotent stem cell that can be isolated from body tissue1 Oct 2026US 2026/0297512 A1MuseCell Innovations Pte. Ltd.
- Compositions, systems and methods for programming immune cell function through targeted gene regulation1 Oct 2026US 2026/0297545 A1Duke University
- Methods For Inhibiting Neuronal Degeneration To Preserve Residual Functionality And Enhance Axonal Fusion17 Sep 2026US 2026/0273141 A1
- Therapy3 Sep 2026US 2026/0258363 A1Plasticell Limited
Most cited
By later US patents
- Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production77US 8,129,182 B2ViaCyte, Inc. · 2012
- Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production37US 8,603,811 B2ViaCyte, Inc. · 2013
- Methods for production of platelets from pluripotent stem cells and compositions thereof18US 9,763,984 B2Astellas Institute for Regenerative Medicine · 2017
- Methods for production of platelets from pluripotent stem cells and compositions thereof17US 10,426,799 B2Astellas Institute for Regenerative Medicine · 2019
- Methods for production of platelets from pluripotent stem cells and compositions thereof17US 9,993,503 B2Astellas Institute for Regenerative Medicine · 2018